首页 › 基金 › Anther Capital Ltd › BLTE

Anther Capital Ltd 对 BLTE 的持仓历史

BELITE BIO INC · 医疗保健

Anther Capital Ltd 在 Q3 2026 的 13F 申报中披露持有 BLTE(BELITE BIO INC)6,070 股,市值约 US$1.0M,约占其申报组合的 0.39%,在其申报持仓中市值排名第 9 位。 Anther Capital Ltd 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)6.07K 股
申报持仓市值$1.03M
组合权重0.39%
首次申报Q3 2026
最近变动新进
更新于2026-11-12

最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR

Anther Capital Ltd 对 BLTE 的持仓演变

Anther Capital Ltd 于 Q3 2026 首次披露 BLTE 持仓:6,070 股(约 US$1.0M)。

逐季持仓明细

季度股数金额变化
Q3 2026 6.07K $1.03M 新进

关于 BLTE 与 13F 数据

BLTE(BELITE BIO INC)属于医疗保健行业。我们追踪的基金中还有 67 只申报持有 BLTE,申报仓位最大的包括:Darwin Global Management, Ltd. (US$456.6M), Paradigm Biocapital Advisors LP (US$189.8M), RTW INVESTMENTS, LP (US$110.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BLTE 的基金

查看 BLTE 的全部基金持有人 →

常见问题

How long has Anther Capital Ltd held BLTE?

Anther Capital Ltd has disclosed BLTE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Anther Capital Ltd's current position in BLTE?

As of Q3 2026, Anther Capital Ltd holds 6.07K shares of BLTE (BELITE BIO INC), valued at $1.03M, representing 0.39% of its reported portfolio and ranking #9.

Has Anther Capital Ltd been buying or selling BLTE?

In the latest 13F filing (Q3 2026), Anther Capital Ltd newly opened its position in BLTE.

Which other funds hold BLTE?

Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.